Questo prodotto usufruisce delle SPEDIZIONI GRATIS
selezionando l'opzione Corriere Veloce in fase di ordine.
Pagabile anche con 18App Bonus Cultura e Carta del Docente
It also explores the relationship between sex-steroid withdrawal and the development of brain symptoms such as hot flushes, sleep disorders, mood changes, depression and also cognitive disorders and dementia, as well as the effects of hormone menopause therapy on such symptoms and diseases.
Starting with obstetrical history and cardiovascular risk in later life, the second part of the book examines the effects of estrogens and progestogens on vascular tissues, atherosclerosis and coronary heart diseases, as well as the impact of hormone replacement therapies on cardiovascular risks and mortality.
This volume is a useful, clear and up-to-date tool for gynecologists, endocrinologists, neurologists and cardiologists, and serves as a valuable source of information for all physicians involved in women’s health.1. Neuroendocrine changes of the menopausal transition
2. The neurological and immunological transitions of the perimenopause: implications for post-menopausal neurodegenerative disease
3. Estrogenic regulation of neuroprotective and neuroinflammatory mechanisms: implications for depression and cognition4. "Estetrol and its effects on damaged brain Running title: Estetrol and brain
5. ADRENAL ANDROGENS IMPACT ON NEUROSTEROIDS6. Do menopausal symptoms account for the declines in cognitive function during the menopausal transition?
7. Allopregnanolone as a therapeutic to regenerate the degenerated brain
8. Reproductive Depression and the response to Hormone Therapy
9. Sex, Gender, and the Decline of Dementia
10. Obstetric History and cardiovascular disease (CVD) Risk11. HRT and Cardiovascular disease
12. Estetrol, a Native Estrogen with Specific Actions in Tissues (NEST): Unique vascular benefits
13. VASCULAR EFFECTS OF PROGESTOGENS
14. Sex differences, progesterone and ischemic stroke
15. Atherogenesis - Estrogen Induction of polysialylated nCAM (PSA-nCAM) Blocks Monocyte Capture by Vascular Endothelial Cells
16. Cardiovascular risk in climacteric women: when to begin the hormone treatment?
17. HRT for the primary prevention of coronary heart disease
18. SYMPTOMS AND HORMONES: FINE-TUNING ATHEROSCLEROTIC RISK ?19. Cardiovascular mortality risk and HRT"
20. HT: Pharmacology tailored to women´s health"
Il sito utilizza cookie ed altri strumenti di tracciamento che raccolgono informazioni dal dispositivo dell’utente. Oltre ai cookie tecnici ed analitici aggregati, strettamente necessari per il funzionamento di questo sito web, previo consenso dell’utente possono essere installati cookie di profilazione e marketing e cookie dei social media. Cliccando su “Accetto tutti i cookie” saranno attivate tutte le categorie di cookie. Per accettare solo deterninate categorie di cookie, cliccare invece su “Impostazioni cookie”. Chiudendo il banner o continuando a navigare saranno installati solo cookie tecnici. Per maggiori dettagli, consultare la Cookie Policy.